Tinnitus after cochlear implant surgery
Conditions
Interventions
Experimental group:Ginkgo bilobaand Prednisone Acetate Tablets
Positive control group:Prednisone Acetate Tablets
Blank group:None
Sponsors
Shandong Second Provincial General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-70 years old (including 18 years old and 70 years old); 2. Unilateral cochlear implant implantation surgery completed by the clinical treatment team; 3. Preoperative tinnitus course >=3 months; 4. On the second day after surgery, the THI, TFI and VAS scores were all aggravated compared with before. 5. No obvious abnormalities in blood analysis and liver and kidney function tests; 6. Sufficient written or speaking skills (or able to participate in research activities with the assistance of a guardian) and willing to comply with the study protocol; 7. Able to complete the online study questionnaire using a computer or other suitable device with Internet access.
Exclusion criteria
Exclusion criteria: 1. Patients with existing cochlear implants; 2. Patients under 18 years old; 3. Those who have significantly reduced or disappeared tinnitus after surgery; 4. Psychiatric tinnitus or antidepressant drug users; 5. Concomitant use of other anti-tinnitus drugs; 6. Those with severe cognitive impairment or neurological diseases; 7. Those with contraindications to Kinnadol (such as allergies or coagulation mechanism disorders); 8. Other conditions that the investigator deems unsuitable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Functional Index (TFI);The Tinnitus Handicap Inventory (THI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Generalized Anxiety Disorder (GAD-7);Visual Analogue Scale (VAS);Patient Health Questionnaire (PHQ-9);Insomnia Severity Index (ISI); | — |
Countries
China
Contacts
Public ContactJianfen Luo
Shandong Provincial Second People's Hospital
Outcome results
None listed